Viewing Study NCT01884961


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2025-12-31 @ 7:44 PM
Study NCT ID: NCT01884961
Status: COMPLETED
Last Update Posted: 2025-01-13
First Post: 2013-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module